Caprock Group LLC Sells 997 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Caprock Group LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 8.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 10,591 shares of the company’s stock after selling 997 shares during the period. Caprock Group LLC’s holdings in HCA Healthcare were worth $4,305,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Capital World Investors boosted its position in shares of HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares during the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare in the second quarter worth about $131,527,000. Darsana Capital Partners LP boosted its position in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after acquiring an additional 400,000 shares during the last quarter. Swedbank AB bought a new position in HCA Healthcare during the first quarter valued at $95,882,000. Finally, Argent Capital Management LLC raised its position in shares of HCA Healthcare by 1,215.6% during the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock valued at $51,493,000 after buying an additional 148,092 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 2.1 %

Shares of NYSE:HCA opened at $335.89 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $245.03 and a 52-week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $85.08 billion, a price-to-earnings ratio of 15.08, a PEG ratio of 1.32 and a beta of 1.68. The business has a 50-day moving average price of $384.12 and a 200-day moving average price of $358.11.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. KeyCorp reduced their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Leerink Partners boosted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock worth $5,608,990 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.